KI
TNDM icon

Kula Investments’s Tandem Diabetes Care TNDM Stock Holding History

Kula Investments’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-6,127
Closed -$275K – 847
2022
Q4 		$275K Buy
+6,127
New +$277K 0.08% 418

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Kula Investments's TNDM Position: Q1 2023 in Review

Kula Investments sold out of Tandem Diabetes Care (TNDM) in Q1 2023, closing a stake of 6,127 shares — an estimated $275K sold.

Kula Investments first reported a position in TNDM in Q4 2022 and held it in 1 quarter. The position peaked at $275K in Q4 2022. 273 funds tracked by Wall St. Rank hold TNDM as of Q1 2023.

  • Kula Investments reported no remaining Tandem Diabetes Care position as of Q1 2023 after selling out during the quarter.
  • Kula Investments sold 6,127 Tandem Diabetes Care shares in Q1 2023, an estimated $275K.
  • Kula Investments first reported a position in Tandem Diabetes Care in Q4 2022 and held it in 1 quarter.
  • Kula Investments's Tandem Diabetes Care position peaked at $275K in Q4 2022.
  • 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2023.

Based on Kula Investments's 13F filing for Q1 2023, filed 15 May 2023.